Hui-Gene Therapeutics engages in gene editing and gene therapy in the genomic medicine sector
Hui-Gene Therapeutics engages in gene editing and gene therapy in the genomic medicine sector. The company works on the discovery, engineering, and development of gene editing tools and therapies, utilizing CRISPR-cas13 and CRISPR-cas12 technologies. Hui-Gene Therapeutics addresses therapeutic needs in ophthalmology, neurology, and neuromuscular diseases.